Rankings
▼
Calendar
RAPT Q3 2022 Earnings — RAPT Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
RAPT
RAPT Therapeutics, Inc.
$959M
Q3 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
-100.0% YoY
Gross Profit
$0
Operating Income
-$22M
Net Income
-$21M
EPS (Diluted)
$-5.04
QoQ Revenue Growth
-100.0%
Cash Flow
Operating Cash Flow
-$17M
Free Cash Flow
-$17M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$209M
Total Liabilities
$20M
Stockholders' Equity
$189M
Cash & Equivalents
$28M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$966,000
-100.0%
Gross Profit
$0
$966,000
-100.0%
Operating Income
-$22M
-$19M
-17.0%
Net Income
-$21M
-$19M
-13.9%
← FY 2022
All Quarters
Q4 2022 →